Compare ATCX & PLSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATCX | PLSM |
|---|---|---|
| Founded | 2016 | 2014 |
| Country | Brazil | Israel |
| Employees | 13 | 63 |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.8M | 22.0M |
| IPO Year | N/A | N/A |
| Metric | ATCX | PLSM |
|---|---|---|
| Price | $5.54 | $3.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $13.75 | N/A |
| AVG Volume (30 Days) | ★ 37.6K | 2.4K |
| Earning Date | 03-16-2023 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $827,667.00 | N/A |
| Revenue Next Year | $166.45 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.39 | $3.00 |
| 52 Week High | $14.01 | $6.85 |
| Indicator | ATCX | PLSM |
|---|---|---|
| Relative Strength Index (RSI) | 49.90 | 53.28 |
| Support Level | $4.66 | $3.70 |
| Resistance Level | $5.62 | $3.93 |
| Average True Range (ATR) | 0.34 | 0.17 |
| MACD | 0.06 | 0.04 |
| Stochastic Oscillator | 54.78 | 65.67 |
Atlas Critical Minerals Corp is a mineral exploration and development company focused on critical minerals projects and properties in Brazil. The company's portfolio principally includes mineral properties for rare earths, graphite, titanium, copper, uranium, and nickel. It also owns mineral rights for iron ore, quartzite, gold, and diamond properties. The company's project portfolio includes the Alto Paranaiba, Malacacheta, Arcos, Goias, Tocantins, Rio Piracicaba, and other projects.
Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.